Drug Shortage Report for ZEJULA
| Report ID | 200374 |
| Drug Identification Number | 02489783 |
| Brand name | ZEJULA |
| Common or Proper name | niraparib capsules |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | NIRAPARIB |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 84 |
| ATC code | L01XX |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-07-31 |
| Estimated end date | |
| Actual end date | 2023-09-25 |
| Shortage status | Resolved |
| Updated date | 2023-09-28 |
| Company comments | No further supply of capsules available. Zejula can be ordered in the tablet format as of September 25, 2023. For any questions, contact GSK Customer Service at 1-800-387-7374 or cacsu@gsk.com. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-09-28 | French | Compare |
| v5 | 2023-09-28 | English | Compare |
| v4 | 2023-08-02 | French | Compare |
| v3 | 2023-08-02 | English | Compare |
| v2 | 2023-07-28 | French | Compare |
| v1 | 2023-07-28 | English | Compare |
Showing 1 to 6 of 6